Table 4 Comparison of the clinical and laboratory in different studies of patients with infectious mononucleosis secondary to Epstein-Barr virus
Clinical and laboratory data | Authors | ||||
|---|---|---|---|---|---|
Balfour(9), 2005 (%) | Grotto(10), 2003 (%) | Rea(11), 2001 (%) | Gao(12), 2011 (%) | Present study 2011 (%) | |
Lymphadenopathy | 95 | 88.9 | 57 | 95 | 89.5 |
Fever | 30 | 79 | 45 | 92.3 | 79.7 |
General body pain | NR | NR | 77 | NR | 69.3 |
Pharyngitis | 100 | 95 | 73 | 83.5 | 55.2 |
Hepatomegaly | 25 | 36.7 | 7 | 58.1 | 47.2 |
Splenomegaly | 35 | 53.3 | 8 | 47.4 | 36.8 |
Exanthema | 17 | 16.7 | 15 | 14.8 | 16.5 |
Jaundice | NR | 16.7 | <10 | 0 | 9.8 |
Myalgia | 50 | 32.4 | 0 | 0 | 0 |
Palpebral edema | 10 | NR | 0 | 11.5 | 0.61 |
Atypic Lymphocytosis | NA | 59.2 | 85.7 | 51.9 | 24.5 |
Transaminasemia | NA | 57.9 | 31 | 48.6 | 30.9 |
Hyperbilirubinemia | NA | 14.9 | 6 | NR | 42.1 |